HealthLeaders Media March 26, 2024
Marie DeFreitas

Some states are hesitant to cover the popular drugs.

Weight loss drugs have soared in popularity; while some states have been hesitant to cover them, others have not. A recent JAMA study found that five states offer unrestricted coverage of GLP-1 drugs Wegovy and Saxenda that were approved for weight loss.

The data from this study comes from formularies for 47 state Medicaid programs from the first quarter of 2023.

The study found that a total of ten states cover Saxenda or Wegovy for weight loss, while five of those states offered restricted access through...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Govt Agencies, Insurance, Medicaid, Patient / Consumer, Pharma / Biotech, Provider, States, Survey / Study, Trends
Related Articles:
California lawmakers trying again for single-payer
Millions Were Booted From Medicaid. The Insurers That Run It Gained Revenue Anyway.
Improving Access To Medigap When Beneficiaries Leave Medicare Advantage
Centene: States slow to pick up Medicaid weight-loss drug coverage
Steward's leases make hospitals 'less attractive' to buyers, Mass. health secretary says

Share This Article